Titan Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2015,
inter-alia to (i) consider and approve audited financial results of the Company for the quarter/year ended March 31, 2015 and (ii) recommendation of dividend, if any, for the financial year 2014-15.
Further, Trading window will be closed accordingly and trading in the securities of the company is prohibited by Directors, Senior/Designated Employees and Auditors from May 25, 2015 to May 29, 2015 (Both days Inclusive).
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
